The "Guidelines" for Pharmaceutical Investment Enterprises to Formulate Incentive Systems

Pharmaceutical investment experts pointed out that when pharmaceutical investment promotion companies formulate incentive systems, they must embody the principles of fairness and fairness. A person's satisfaction with the remuneration received must be compared not only with his contribution to labor but also with other people or historical circumstances. Pharmaceutical investment promotion companies must issue a set of highly praised incentive systems on the basis of extensive consultation with employees, and continue to revise and improve them.

When applying incentive policies, managers must be fair and just, without any prejudice or preference, and they should not show any unfair language or behavior.

For pharmaceutical investment companies, they should seize the right time to allow time for companies to succeed. In fact, pharmaceutical investment promotion is a phased work. It can not be endless investment, it will cause people's mistrust. Once the investment is over, they immediately face the sales work. If the investment promotion is successful, the service team should be quickly established to provide related services; if the pharmaceutical investment fails, the meeting will be immediately summed up to reduce the greater losses. For the late-stage finishing work, it is the sublimation of the company's own self-summary, and pharmaceutical investment promotion companies should pay attention to it.

In addition, the outstanding employees in the pharmaceutical investment enterprise can not stand without the support and promotion of the team, department posts. A good group environment is a prerequisite for the growth and progress of employees. In the implementation of incentive policies, the correct handling of the relationship between incentive individuals and incentive groups will help employees and the collective to promote mutual promotion. If we ignore the individual role, only focusing on the incentives of the group may result in a good egalitarianism. On the contrary, if we place too much emphasis on individual contributions and disregard the existence of group factors, it will easily affect everyone's enthusiasm and fail to work together. Therefore, in the use of incentives, we should adhere to the organic combination of individual incentives and group incentives, and at the same time pay attention to the use of comprehensive and diversified incentives.

Of course, the management of old customers should also be done well. However, in the view of pharmaceutical investment promotion, while the management of old customers is well done, another aspect of the development of pharmaceutical investment enterprises is the development of new customers. It can be said that which pharmaceutical investment enterprise has a stronger ability to develop new customers, then the company's sales and profits will be more secure. In the past few years, advertisements for pharmaceutical companies were initially advertised as kings. As long as media campaigns are well done, there will be a large number of agents who will take the initiative to seek out product agents. However, nowadays, with the unprecedented prosperity of the media and the more sensible agents, if media information is not published accurately, the effect is not good, and resources are wasted.